The development of pharmacogenomic models to predict drug response

Abstract

The medical community as a whole is aware that patients show variable responses to drug treatments but physicians currently lack efficient tools to predict these drug responses and to select appropriate treatments. Coupling our knowledge of genetic polymorphisms with clinical-response data promises a bright future for rapid advances in personalized medicine.